The acute effects of 3,4-methylenedioxymethamphetamine and methamphetamine on driving: A simulator study

Abstract Objectives Illicit drugs such as MDMA and methamphetamine are commonly abused drugs that have also been observed to be prevalent in drivers injured in road accidents. Their exact effect on driving and driving behavior has yet to be thoroughly investigated. Methods Sixty-one abstinent recreational users of illicit drugs comprised the participant sample, with 33 females and 28 males, mean age 25.45 years. The three testing sessions involved oral consumption of 100 mg MDMA, 0.42 mg/kg methamphetamine, or a matching placebo. The drug administration was counter-balanced, double-blind, and medically supervised. At each session driving performance was assessed 3 h and 24 h post drug administration on a computerized driving simulator. Results At peak concentration overall impairment scores for driving ( F 2,118  = 9.042, p F 2,118  = 4.060, p  = 0.020) were significantly different for the daytime simulations. Performance in the MDMA condition was worse than both the methamphetamine ( p  = 0.023) and placebo ( p p  = 0.055). For signaling adherence, poorer signaling adherence occurred in both the methamphetamine ( p  = 0.006) and MDMA ( p  = 0.017) conditions in comparison to placebo in the daytime simulations. Conclusions The findings of this study have for the first time illustrated how both MDMA and methamphetamine effect driving performance, and provide support for legislation regarding testing for the presence of illicit drugs in impaired or injured drivers as deterrents for driving under the influence of illicit drugs.